Geron Corp. [GERN] stock is trading at $4.74, up 4.87%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The GERN shares have gain 6.52% over the last week, with a monthly amount glided 2.60%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Geron Corp. [NASDAQ: GERN] stock has seen the most recent analyst activity on September 09, 2024, when Leerink Partners initiated its Outperform rating and assigned the stock a price target of $7. Previously, Robert W. Baird downgraded its rating to Neutral on April 30, 2024, and kept the price target unchanged to $4.50. On April 29, 2024, TD Cowen initiated with a Buy rating and assigned a price target of $10 on the stock. Needham reiterated its Buy rating and increased its price target to $5 on March 15, 2024. Goldman upgraded its rating to a Buy but $4 remained the price target by the analyst firm on September 12, 2023. Goldman started tracking with a Neutral rating for this stock on March 28, 2023, and assigned it a price target of $3. In a note dated October 28, 2022, Wedbush initiated an Outperform rating and provided a target price of $5 on this stock.
Geron Corp. [GERN] stock has fluctuated between $1.64 and $5.34 over the past year. Currently, Wall Street analysts expect the stock to reach $5.92 within the next 12 months. Geron Corp. [NASDAQ: GERN] shares were valued at $4.74 at the most recent close of the market. An investor can expect a potential return of 24.89% based on the average GERN price forecast.
Analyzing the GERN fundamentals
Geron Corp. [NASDAQ:GERN] reported sales of 1.37M for the trailing twelve months, which represents a growth of 2941.38%. Gross Profit Margin for this corporation currently stands at -21.13% with Operating Profit Margin at -165.6%, Pretax Profit Margin comes in at -159.91%, and Net Profit Margin reading is -159.91%. To continue investigating profitability, this company’s Return on Assets is posted at -0.49, Equity is -0.74 and Total Capital is -0.66. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.28.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.63 points at the first support level, and at 4.53 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.79, and for the 2nd resistance point, it is at 4.85.
Ratios To Look Out For
For context, Geron Corp.’s Current Ratio is 3.61. In addition, the Quick Ratio stands at 3.60 and the Cash Ratio stands at 1.14. Considering the valuation of this stock, the price to sales ratio is 2085.60, the price to book ratio is 9.29.
Transactions by insiders
Recent insider trading involved GRETHLEIN ANDREW J, EVP, Chief Operating Officer, that happened on Jul 08 ’24 when 0.67 million shares were sold. EVP, Chief Medical Officer, Feller Faye completed a deal on Jun 10 ’24 to sell 0.29 million shares. Meanwhile, EVP, Corp Strategy & CCO Kapur Anil sold 0.42 million shares on Jun 10 ’24.
